5 Healthcare Plays Powering the Sector’s Big Comeback

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Upgrade Now See Benefits

or

Already have an account? Log in here.

Should You Invest $1,000 in Pfizer Right Now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Ryan Hasson
About The Author

Ryan Hasson

Contributing Author

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
UnitedHealth Group (UNH)
4.9134 of 5 stars
$339.922.9%2.73%19.41Moderate Buy$465.70
Merck & Co., Inc. (MRK)
4.6799 of 5 stars
$133.560.6%2.64%137.69Moderate Buy$155.74
Eli Lilly and Company (LLY)
3.973 of 5 stars
$1,346.40-0.3%0.51%43.70Moderate Buy$1,422.00
Health Care Select Sector SPDR Fund (XLV)N/A$177.24-0.1%1.44%33.45Moderate Buy$177.24
Pfizer (PFE)
3.1226 of 5 stars
$27.41-0.5%6.27%39.16Hold$30.32

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines